OCRN-ICOCS Training Masterclass 

Obsessive Compulsive Spectrum Disorders: from translational models to clinical management

June 19th – 23rd, 2024.

Reserve your virtual spot today!

Directives of the Training Masterclass

At the end of the webinar, participants should have improved their knowledge of OCDs, having achieved new insight in the fields of:

  1. Diagnosis and assessment and standards of care of OCD and OCSDs (nosographic evolution up to DSM-5 and ICD-11, psychometric tools, specificers, subtypes and endophenotypes)
  2. Neurobiology and clinical insights and comorbidity (particularly with major depression and psychosis)
  3. Animal models
  4. Neuroimaging data
  5. Therapeutic interventions (guidelines, integrated treatments, neuromodulation, new drugs, options for resistant cases).

Obsessive Compulsive Spectrum Disorders (OCSDs) are common and disabling conditions that received new impetus from DSM-5 and ICD-11, allocating them in novel and autonomous chapters and encouraging new preclinical and clinical research in the field.

Diagnostic evolution of OCDs had developed by increasing research in the field of neuropsychopharmacology, with new targets and systems being investigated for the development of novel therapeutic agents.

In addition, a rapidly expanding research field is using preclinical, animal models to study pathophysiological mechanisms underlying OCD.

Finally, neuroimaging investigation has allowed identification of abnormalities of the cortico-striatal-thalamic circuitry involved in the etiopathogenesis of OCD. In light of the above, there is an unprecedented need for advancing skills and understanding in the neuropsychopharmacological area of OCD and OCDs.